LabCentral

LabCentral is a shared laboratory and office facility in Cambridge’s Kendall Square that serves as a launchpad for early-stage biotech and life sciences startups. Companies rent fully permitted, ready-to-use lab and office space month to month and can start working at the bench within days. Residents get access to millions of dollars’ worth of shared equipment, along with waste handling, permitting and operational and facilities support, so founders can focus on the science.

Founded in 2013, LabCentral now operates more than 210,000 square feet in Cambridge and Boston, with room for as many as 125 startups and about 1,000 scientists and entrepreneurs. Its flagship site targets pre-seed through Series A companies, while LabCentral 238 offers process development and scale-up space. Coworking areas, conference rooms, kitchens and event programming help residents connect, and sponsors run pitch events and Golden Ticket competitions.

What to Know

• Flagship applicants must have less than $10 million in dilutive funding.
• Bayer’s Co.Lab Cambridge, focused on cell and gene therapy startups, is operated by LabCentral.
• LabCentral 238 is a 100,000-square-foot facility for early-to-mid stage companies scaling toward biomanufacturing.
• LabCentral has published a 2025 impact report.